Abstract:This study explores a previously overlooked nCas9‐centric strategy for enhancement of base editors (BE). Structure‐guided protein engineering establishes nCas9 variants that can commonly enhance a collection of BE tools. In support of their translational potential, the engineered CBE and ABE variants respectively enable 82% and 25% higher rates of editing than the controls in primary human T‐cells. Base editors (BEs) are a recent generation of genome editing tools that couple a cytidine or adenosine deaminase activity to a catalytically impaired Cas9 moiety (nCas9) to enable specific base conversions at the targeted genomic loci. Given their strong application potential, BEs are under active developments toward greater levels of efficiency and safety. Here, a previously overlooked nCas9‐centric strategy is explored for enhancement of BE. Based on a cytosine BE (CBE), 20 point mutations associated with nCas9‐target interaction are tested. Subsequently, from the initial positive X‐to‐arginine hits, combinatorial modifications are applied to establish further enhanced CBE variants (1.1–1.3). Parallel nCas9 modifications in other versions of CBEs including A3A‐Y130F‐BE4max, YEE‐BE4max, CGBE, and split‐AncBE4max, as well as in the context of two adenine BEs (ABE), likewise enhance their respective activities. The same strategy also substantially improves the efficiencies of high‐fidelity nCas9/BEs. Further evidence confirms that the stabilization of nCas9‐substrate interactions underlies the enhanced BE activities. In support of their translational potential, the engineered CBE and ABE variants respectively enable 82% and 25% higher rates of editing than the controls in primary human T‐cells. This study thus demonstrates a highly adaptable strategy for enhancing BE, and for optimizing other forms of Cas9‐derived tools.

Rational Design of Enhanced Nme2Cas9 and Nme2 Cas9 Nucleases and Base Editors

Engineering Nme2Cas9 Adenine Base Editors with Improved Activity and Targeting Scope

Domain-inlaid Nme2Cas9 adenine base editors with improved activity and targeting scope

Two Compact Cas9 Ortholog-Based Cytosine Base Editors Expand the DNA Targeting Scope and Applications In Vitro and In Vivo

Expanding the Genome-Targeting Scope and the Site Selectivity of High-Precision Base Editors

Cas9-orthologue-mediated cytosine and adenine base editors recognizing NNAAAA PAM sequences

nCas9 Engineering for Improved Target Interaction Presents an Effective Strategy to Enhance Base Editing

Multiplexed base editing through Cas12a variant-mediated cytosine and adenine base editors

Efficient C-to-G Base Editing with Improved Target Compatibility Using Engineered Deaminase-nCas9 Fusions.

Efficient and High-Fidelity Base Editor with Expanded PAM Compatibility for Cytidine Dinucleotide

Engineered domain-inlaid Nme2Cas9 adenine base editors with increased on-target DNA editing and targeting scope

Versatile and Efficient Genome Editing with Neisseria Cinerea Cas9

Engineering domain-inlaid SaCas9 adenine base editors with reduced RNA off-targets and increased on-target DNA editing

CRISPR-Cas9 DNA Base-Editing and Prime-Editing

Precise base editing with CC context-specificity using engineered human APOBEC3G-nCas9 fusions

Cooperativity between Cas9 and hyperactive AID establishes broad and diversifying mutational footprints in base editors

Improving Editing Efficiency for the Sequences with NGH PAM Using Xcas9-Derived Base Editors.

A New Compact Adenine Base Editor Generated Through Deletion of HNH and REC2 Domain of SpCas9

Engineering a Precise Adenine Base Editor with Minimal Bystander Editing.

Base editing in Streptomyces with Cas9 deaminase fusions

Highly Efficient Base Editing with Expanded Targeting Scope Using SpCas9‐NG in Rabbits